TABLE 2.
Demographic and clinical characteristics of the patients according to the presence or absence of dementia.
| With dementia | Without dementia | p-value | |
| N° of patients | 23 | 46 | |
| Males, N° (%) | 14 (60.9%) | 28 (60.9%) | 1 |
| Age, years, median (IQR) | 82 (75.5;85) | 80 (75.5; 83.75) | 0.62 |
| N° (%) of patients in different age classes (years) | |||
| 40–49 | 0 | 1 (2,3%) | 1 |
| 50–59 | 2 (8.7%) | 3 (6.5%) | 1 |
| 60–69 | 1 (4.3%) | 3 (6.5%) | 1 |
| 70–80 | 5 (21.7%) | 17 (36.9%) | 0.27 |
| >80 | 15 (65.2%) | 22 (47.8%) | 0.17 |
| Charlson comorbidity index, median (IQR) | 6 (5;7) | 6 (4;6) | 0.06 |
| N° (%) of patients with Charlson index ≥ 2 | 23 (100%) | 43 (93.5%) | 0.54 |
| N° (%) of patients with an underlying chronic disease (dementia) | 23 | 44 | 0.55 |
| With hypertension | 13 (56.8%) | 40 (86.9%) | 0.004 |
| With cardio-vascular disease | 11 (47.8%) | 21/45.6%) | 0.86 |
| With diabetes | 4 (17.4%) | 17 (36.9%) | 0.16 |
| With chronic obstructive pulmonary disease | 8 (34.8%) | 15 (32.6%) | 0.86 |
| With liver cirrhosis | 0 | 2 (4.3%) | 0.55 |
| With malignancy | 2 (8.7%) | 6 (13%) | 0.71 |
Bold value indicate our way to highlight statistically significant p-value.